[1]
M. Seyedifar, “Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran”, Int J Hematol Oncol Stem Cell Res, vol. 10, no. 4, pp. 224-231, Oct. 2016.